CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

NeoGenomics (NEO) Financial Analysis | CapyFin

NeoGenomics

NEO · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reports earnings in 9 days

before market opens

Previous year: $172M

Previous year: $0.04

Average revenue per clinical test

Previous year: $465

Gross profit margin (GAAP)

Previous year: 44.9%

Adjusted gross profit margin (non-GAAP)

Previous year: 48%

Previous year: $77.3M

Cash and Equivalents

Previous year: $387M

Previous year: $1.64B

Loading...

NeoGenomics

Unlock previous datapoints

NeoGenomics

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.08B

P/E Ratio

52.19

Sector

N/A

Industry

N/A

52-Week High

$13.2

52-Week Low

$4.82

Average revenue per clinical test

$488

Gross profit margin (GAAP)

43.8%

Adjusted gross profit margin (non-GAAP)

46.4%

Adjusted EBITDA (non-GAAP)

$13.4M

Number of tests performed

356.14K